Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IVAX in China

Executive Summary

Signs a letter of intent to acquire a 51% stake in a Chinese pharmaceutical factory (Baker-Norton-China Pharmaceutical Company), based in Yunan, China. The company will produce and market "a wide range of immediate and controlled release tablets and capsules as well as a line of pediatric and dermatologic products" for domestic use and Artmetheri, an anti-malarial drug, of which 70% will be exported. Pending finalization of the agreement, IVAX will contribute $ 750,000 in cash and technical expertise to the deal....
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS019908

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel